These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10894904

  • 1. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease.
    Kim HK, Song KS, Park YS, Yun YS, Shim WH.
    Cardiology; 2000; 93(1-2):31-6. PubMed ID: 10894904
    [Abstract] [Full Text] [Related]

  • 2. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [Abstract] [Full Text] [Related]

  • 3. Aberrations of the tissue factor pathway in patients positive for lupus anticoagulant.
    Wakita Y, Wada H, Nakase T, Nakasaki T, Shimura M, Hiyoyama K, Mori Y, Gabazza EC, Nishikawa M, Deguchi K, Shiku H.
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):10-5. PubMed ID: 10725976
    [Abstract] [Full Text] [Related]

  • 4. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome.
    Amengual O, Atsumi T, Khamashta MA, Hughes GR.
    Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575
    [Abstract] [Full Text] [Related]

  • 5. Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation. Response of nonadherent cells to lipopolysaccharide.
    Nguyên P, Broussas M, Cornillet-Lefèbvre P, Potron G.
    Transfusion; 1999 Sep; 39(9):975-82. PubMed ID: 10533824
    [Abstract] [Full Text] [Related]

  • 6. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
    Basavaraj MG, Sovershaev MA, Egorina EM, Gruber FX, Bogdanov VY, Fallon JT, Østerud B, Mathiesen EB, Hansen JB.
    Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
    [Abstract] [Full Text] [Related]

  • 7. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM, Pepe G, Attanasio M, Falciani M, Abbate R, Prisco D, Fedi S, Giusti B, Brunelli T, Giusti B, Brunelli T, Comeglio P, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
    [Abstract] [Full Text] [Related]

  • 8. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.
    Caplice NM, Mueske CS, Kleppe LS, Simari RD.
    Circulation; 1998 Sep 15; 98(11):1051-7. PubMed ID: 9736590
    [Abstract] [Full Text] [Related]

  • 9. The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.
    Basavaraj MG, Gruber FX, Sovershaev M, Appelbom HI, Osterud B, Petersen LC, Hansen JB.
    Thromb Res; 2010 Nov 15; 126(5):418-25. PubMed ID: 20723970
    [Abstract] [Full Text] [Related]

  • 10. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease.
    Saito Y, Wada H, Yamamuro M, Inoue A, Shimura M, Hiyoyama K, Gabazza EC, Isaka N, Shiku H, Takeya H, Suzuki K, Kumeda K, Kato H, Nakano T.
    Am J Hematol; 1999 Aug 15; 61(4):238-42. PubMed ID: 10440909
    [Abstract] [Full Text] [Related]

  • 11. Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
    Kopp CW, Steiner S, Priglinger U, Christ G, Probst P, Maurer G, Minar E, Huber K.
    Blood Coagul Fibrinolysis; 2003 Jun 15; 14(4):379-86. PubMed ID: 12945880
    [Abstract] [Full Text] [Related]

  • 12. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M, Ranlall N, Patel G, Rutlin A, Jehanli A, Kakkar VV.
    Blood Coagul Fibrinolysis; 2000 Apr 15; 11(3):285-91. PubMed ID: 10870809
    [Abstract] [Full Text] [Related]

  • 13. Monocyte tissue factor response is decreased in patients with hyperlipidemia.
    Rugeri L, Susen S, Bard JM, Corseaux D, Gavériaux V, Devos P, Lecerf JM, Duriez P, Jude B.
    Thromb Res; 1999 Nov 15; 96(4):283-92. PubMed ID: 10593431
    [Abstract] [Full Text] [Related]

  • 14. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I, Wysokin Ski W, Karnicki K, Adamiec R.
    Int Angiol; 2008 Aug 15; 27(4):296-301. PubMed ID: 18677291
    [Abstract] [Full Text] [Related]

  • 15. [Effects of tissue factor pathway inhibitor-1 on no-reflow in a rabbit model].
    Luo JG, Chen YD, Tian F, Wang CH, Lü Y, Yang XX, Lü SZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec 15; 37(12):1113-8. PubMed ID: 20193184
    [Abstract] [Full Text] [Related]

  • 16. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M, Zekanowska E, Uszyński W, Kuczyński J, Zyliński A.
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep 15; 158(1):37-41. PubMed ID: 21664032
    [Abstract] [Full Text] [Related]

  • 17. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.
    Kopp CW, Siegel JB, Hancock WW, Anrather J, Winkler H, Geczy CL, Kaczmarek E, Bach FH, Robson SC.
    Transplantation; 1997 Mar 15; 63(5):749-58. PubMed ID: 9075849
    [Abstract] [Full Text] [Related]

  • 18. Tissue factor and homocysteine levels in ischemic heart disease are associated with angiographically documented clinical recurrences after coronary angioplasty.
    Marcucci R, Prisco D, Brunelli T, Pepe G, Gori AM, Fedi S, Capanni M, Simonetti I, Federici G, Pastore A, Abbate R, Gensini GF.
    Thromb Haemost; 2000 Jun 15; 83(6):826-32. PubMed ID: 10896233
    [Abstract] [Full Text] [Related]

  • 19. [Tissue factor and tissue factor pathway inhibitor during specific bronchial challenge in allergic asthma patients].
    Kemona-Chetnik I, Bodzenta-Lukaszyk A, Kucharewicz I, Rogalewska AM.
    Przegl Lek; 2005 Jun 15; 62(2):98-101. PubMed ID: 16095153
    [Abstract] [Full Text] [Related]

  • 20. Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins.
    Zawadzki C, Susen S, Richard F, Haulon S, Corseaux D, Jeanpierre E, Vincentelli A, Lucas C, Torpier G, Martin A, Van Belle E, Staels B, Jude B.
    Atherosclerosis; 2007 Dec 15; 195(2):e117-25. PubMed ID: 17196206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.